Study of Karenitecin (BNP1350) in Patients With Brain Tumors
Clinical trial NCT00062478 · COMPLETED
Trial details
- NCT number
- NCT00062478
- Sponsor
- BioNumerik Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-10-01
- Primary completion
- 2002-08-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.